1)難治性炎症性腸管障害に関する調査研究班プロジェクト研究グループ:エビデンスとコンセンサスを統合した潰瘍性大腸炎の診察ガイドライン.http://minds.jcqhc.or.jp/n/medical_user_main.php
2)Assche GV, et al:Second European evidence-based consensus on the diagnosis and management of ulcerative colitis;Special situations. https://www.ecco-ibd.eu/images/6_Publication/6_3_ECCO%20Guidelines/2012_UC_Consensus_3_Special_situations.pdf
3)Kornbluth A, Sachar DB:Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 105:501-523, 2010
4)Shinozaki M, et al:Chronic active disease reflects cancer risk in ulcerative colitis. Jpn J Cancer Res 90:1066-1070, 1999
5)Cairns SR, et al:Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups(update from 2002). Gut 59:666-689, 2010
6)大塚和朗,他:拡大内視鏡はサーベイランスに有効か.消内視鏡24:1863-1868, 2012
7)Canavan C, et al:Meta-analysis;Colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23:1097-1104, 2006
8)Freeman HJ:Colorectal cancer risk in Crohn's disease. World J Gastroenterol 14:1810-1811, 2008
9)篠崎 大:クローン病と下部消化管癌―本邦の現況―.日本大腸肛門病会誌61:353-363, 2008
10)Itzkowitz SH, et al:Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11:314-321, 2005
11)National Institute for Health and Clinical Excellence:Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas. http://www.nice.org.uk/nicemedia/live/13415/53641/53641.pdf